United states (us)
Capital-at-risk products – kickouts in particular – remain the leading products the UK. In the US, Barclays is back in force with the biggest market share in September
HSBC has released a note linked to the Russell 2000 that offers investors full upside participation, plus a fixed 15% if the index stays flat during the three-year term
Regulatory mindset 'creates no value' for US insurers
The computational requirements of Solvency II are driving the need for more computing power and data storage accessible on a scalable basis. Early adopters are leveraging cloud computing for their Solvency II implementation. Others are taking a more cautious approach, waiting for the industry to address key concerns such as security before they to embrace computing.
More United states (us) articles
Industry trying to focus on Orsa and regulatory capital
Serious attack will expose flaws in incident response programmes
Barclays is offering a 12-month reverse convertible based on the stock of Valeant Pharmaceuticals. The high coupon is typical of shorter-term structures of this type that allow for some risk to capital
The US structured products market in August showed exactly the same features and preferences as it so often does – an obsession with leveraged return notes and the S&P 500
New York commissioner publicly breaks ranks claiming new system will be ineffective
In response to industry fears of a collateral crunch, regulators have revised the proposed rules on margining for uncleared over-the-counter (OTC) derivatives.You can find out more by downloading this white paper here.